|
SLC35F2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.57403999999639E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.439400E-04 |
| Normal-vs-Stage2 |
2.006000E-02 |
| Normal-vs-Stage3 |
1.319790E-02 |
| Normal-vs-Stage4 |
2.798500E-03 |
| Stage1-vs-Stage2 |
4.243200E-01 |
| Stage1-vs-Stage3 |
3.473600E-01 |
| Stage1-vs-Stage4 |
8.183800E-03 |
| Stage2-vs-Stage3 |
8.405800E-01 |
| Stage2-vs-Stage4 |
1.316210E-01 |
| Stage3-vs-Stage4 |
2.395400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.604800E-04 |
| Normal-vs-AfricanAmerican |
3.9597999999974E-05 |
| Normal-vs-Asian |
1.849800E-01 |
| Caucasian-vs-AfricanAmerican |
7.653600E-02 |
| Caucasian-vs-Asian |
1.895230E-01 |
| AfricanAmerican-vs-Asian |
5.372800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.418800E-04 |
| Normal-vs-Female |
2.02099999957461E-07 |
| Male-vs-Female |
1.058250E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.759700E-03 |
| Normal-vs-Extreme_Weight |
5.417100E-03 |
| Normal-vs-Obese |
2.019300E-04 |
| Normal-vs-Extreme_Obese |
9.329900E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.779400E-01 |
| Normal_Weight-vs-Obese |
5.328400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.869600E-01 |
| Extreme_Weight-vs-Obese |
7.468400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.669800E-01 |
| Obese-vs-Extreme_Obese |
1.443650E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.225200E-04 |
| Normal-vs-Age(41-60Yrs) |
1.28309999958276E-07 |
| Normal-vs-Age(61-80Yrs) |
3.008200E-02 |
| Normal-vs-Age(81-100Yrs) |
4.416400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.164400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.000200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.495100E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.791990E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.647700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.881800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.952400E-04 |
| Normal-VS-Type2 PRCC |
1.184430E-02 |
| Normal-VS-KIRP CIMP |
1.381740E-04 |
| Normal-VS-Unclassified PRCC |
7.759800E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.412600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.48959799629279E-11 |
| Type1 PRCC-VS-Unclassified PRCC |
2.852800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.642500E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
7.377900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.74509999970741E-07 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.483800E-02 |
| Normal-vs-N1 |
5.620200E-04 |
| Normal-vs-N2 |
1.028200E-02 |
| N0-vs-N1 |
1.301660E-02 |
| N0-vs-N2 |
3.746000E-01 |
| N1-vs-N2 |
5.685800E-01 |
|
|
